Do Analysts Expect DENTSPLY SIRONA Inc (XRAY) Stock to Rise After It Is Up 4.83% in a Month?

Wall Street is positive on DENTSPLY SIRONA Inc (XRAY). On average, analysts give DENTSPLY SIRONA Inc a Buy rating. The average price target is $35.7, which means analysts expect the stock to increase by 13.55% over the next twelve months. That average ranking earns DENTSPLY SIRONA Inc an Analyst Rating of 26, which is better than 26% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating XRAY a Buy today. Find out what this means to you and get the rest of the rankings on XRAY!

See Full XRAY Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With DENTSPLY SIRONA Inc Stock Today?

DENTSPLY SIRONA Inc (XRAY) stock is up 0.38% while the S&P 500 is lower by -0.21% as of 2:49 PM on Monday, Nov 27. XRAY is higher by $0.12 from the previous closing price of $31.32 on volume of 1,406,922 shares. Over the past year the S&P 500 is higher by 14.77% while XRAY is higher by 3.22%. XRAY lost -$1.01 per share the over the last 12 months. Click Here to get the full Stock Report for DENTSPLY SIRONA Inc stock.